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Free-Breathing 2D Time-of-Flight Pulmonary MRA at 3T 
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INTRODUCTION 
Contrast-enhanced pulmonary MRA (PMRA) has been widely used in clinical diagnosis. However, such technique is not desirable for certain patients with difficult in 
holding breath or cooperating during MRI scan. In non-contrast-enhanced PMRA, 2D time-of-flight (TOF) approach has not been widely employed in PMRA due to 
low SNR.  At high field such as 3T, increase in signal intensity and T1 increase may offset this disadvantage. This study aims to optimize and evaluate a free-breathing 
2D TOF PMRA protocol at 3T.  The protocol is based on a coronal T1-weighted turbo field echo (TFE) sequence with static tissue suppression using magnetization 
transfer (MT) plus selective inverse recovery (SIR), spectral fat saturation, cardiac VCG gating, respiratory navigator gating, and parallel imaging (SENSE).   
METHOD 
The proposed 2D TOF PMRA sequence is shown in Fig.1. The diagram represents 
one cardiac cycle.  After triggering delay (TD) adjusted to the individual heart rate, 
a slice selective 180° pulse is applied to invert the magnetization of the stationary 
tissue within the slice. The inversion delay (TI) is chosen to null the static tissue 
signal approximately at the start of TFE acquisition. Meanwhile, an off-resonance 
MT irradiation is performed to suppress static tissue signal. Because MT reduces 
the effective T1 of the thoracic and cardiac muscle [1], shorter TI is needed for IR 
nulling. Optimal TI also allows adequate TOF inflow of non-inverted fresh arterial 
and venous blood into the imaging slice. Then a 2D coronal T1-weighted 
segmented TFE acquisition is performed during the relatively stable terminal 
diastole phase to minimize blood spin dephasing and motion-induced 
discontinuities between consecutive 2D slices.  To suppress fat tissue, a frequency 
selective adiabatic inversion pulse (SPAIR) is applied prior to each TFE shot. In 
addition, the pencil-beam navigator gating is employed by detecting the spatial 
position of locomotory diaphragm.  
All experiments were performed on a 3 T Philips Achieva system with the peak gradient amplitude of 80mT/m and the gradient switch rate of 200mT/m/s. 12 healthy 
volunteers (age 20-67, 8 men, 4 women) were studied with informed consent.  A 6-element synergy coil was used for SENSE parallel acquisition. The 2D coronal 
T1-weighted segmented TFE sequence had the shortest TR/TE=3.4ms/1.45ms and partial echo to minimize the strong T2* effect in lung; TFE factor=30. FOV=370mm 
with 80% rectangular FOV; acquisition matrix of 256×218; in-plane spatial resolution=1.45mm×1.84mm; number of acquisitions (NSA) =2-4; and SENSE factor of 2. 
Data was collected with centric reordering and 3/5th partial Fourier phase encoding. For respiratory compensation, the leading type of navigator echo technique was 
implemented by positioning the 2/3 of beam within the right diaphragm dome and 1/3 on the lung, navigator length of 50mm and the acceptance window of 4 mm. 
RESULTS 
The proposed pulmonary MRA protocol was performed with free-breathing comfort in all 12 volunteers. The data acceptance rate in respiratory navigator was ~50% on 
average. TI, flip angle, and acquisition parameters were experimentally optimized.  The optimal TI and flip angle were found to be ~300ms and 30˚, respectively (see 
Figs. 2 and 3).  With these optimized parameters, satisfactory pulmonary MRA were achieved.  Fig. 4 shows a typical front MIP view of these pulmonary MRA 
images.  Note that such image quality permitted the routine visualization of pulmonary arterial branches up to high orders in all subjects (N=12) with good definition.  
CONCLUSION AND DISCUSSION 
A free-breathing 2D TOF pulmonary MRA protocol has been demonstrated at 3T.  The protocol is robust and clinically relevant for patients who are unable to provide 
long breath-holds during MRI scans.  In the sequence proposed (Fig. 1), the selective inverse recovery (SIR) pulse serves to suppress the background static tissue in 
conjunction with the off-resonance MT irradiation. T1 of muscle increases by 30-40% from 1.5T to 3T.  At 3T, MT rate of muscle is close to 90% [2].  Thus the 
optimal TI for effective static tissue suppression found in this study is similar to that reported by Jakob [1]. On the other hand, long TI is desired for strong inflow effect, 
but long TI will reduce the upper limit on the patient heart rate (HR) that can be accommodated by this PMRA protocol. At 3T, we found that TI of ~300ms provides an 
appropriate balance between these factors.  It provides satisfactory pulmonary MRA contrast and can accommodate patient HR up to 140 bpm. Future work in this 
direction includes the separation of pulmonary arterial and venous vessels. 
REFREENCE. 
1, Jakob PM et al. MAGMA15: 10 -17; 
2002.  
2, Stanisz GJ, et al. MRM 54:507-512; 
2005.   
                                         
Fig. 4 Typical pulmonary MRA acquired with the proposed 
protocol (28-yr male, HR 80 bpm, slice thickness 2mm, 80 
slices, TI 300ms, TD 300ms, and flip angle 30˚). 
Fig. 1 Timing diagram of proposed 2D TOF pulmonary MRA sequence. It is 
based on segmented 2D TFE sequence with static tissue suppression using 
magnetization transfer (MT) plus selective inverse recovery (SIR), spectral 
fat saturation, cardiac gating, navigator, and SENSE parallel imaging.   
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